Search results for "LBL"

showing 10 items of 76 documents

Orthotopic Liver Transplantation: T-Tube or Not T-Tube? Systematic Review and Meta-Analysis of Results

2009

Background The purpose of this study was to compare outcomes after duct-to-duct anastomoses with or without biliary T-tube in orthotopic liver transplantation. Methods We pooled the outcomes of 1027 patients undergoing choledocho-choledochostomy with or without T-tube in 9 of 46 screened trials by means of fixed or random effects models. Results The "without T-tube" and "with T-tube" groups had equivalent outcomes for: anastomotic bile leaks or fistulas, choledocho-jejunostomy revisions, dilatation and stenting, hepatic artery thromboses, retransplantation, and mortality due to biliary complications. The "without T-tube" group had better outcomes when considering "fewer episodes of cholangi…

Malemedicine.medical_specialtyQuality Assurance Health Caremedicine.medical_treatmentPeritonitisGallbladder DiseasesPeritonitisLiver transplantationAnastomosisPostoperative ComplicationsOdds RatiomedicineHumansRetrospective StudiesTransplantationbusiness.industryIncidence (epidemiology)Anastomosis SurgicalRetrospective cohort studyOdds ratioRandom effects modelmedicine.diseaseLiver TransplantationSurgeryCholedochostomyMeta-analysisPractice Guidelines as TopicDisease ProgressionFemalebusinessTransplantation
researchProduct

Risk factors for extrahepatic biliary tract carcinoma in men: medical conditions and lifestyle: results from a European multicentre case-control stud…

2007

OBJECTIVES: To identify risk factors of carcinoma of the extrahepatic biliary tract in men. METHODS: Newly diagnosed and histologically confirmed patients, 35-70 years old, were interviewed between 1995 and 1997 in Denmark, Sweden, France, Germany and Italy. Population controls were frequency-matched by age and region. Adjusted odds ratios and 95%-confidence intervals were estimated by logistic regression. RESULTS: The analysis included 153 patients and 1421 controls. The participation proportion was 71% for patients and 61% for controls. Gallstone disease was corroborated as a risk factor for extrahepatic biliary tract carcinoma in men (odds ratio 2.49; 95% confidence interval 1.32-4.70), …

MaleobesityEtiologyEpidemiologyMedizinGastroenterologyBody Mass Index0302 clinical medicineBile Ducts ExtrahepaticCholelithiasisRisk FactorsMedicineAlcohol consumption2. Zero hungerBiliary tract neoplasmeducation.field_of_studySmokingGastroenterologyCase-control studyMenGallstonesMiddle Agedmedical history3. Good healthBiliary tract carcinomaBiliary Tract Neoplasms030220 oncology & carcinogenesisMedical history030211 gastroenterology & hepatologyGallbladder NeoplasmsepidemiologyGallbladder carcinomaAdultmedicine.medical_specialtyAmpulla of Vateralcohol consumptioncase-control studyetiologyPopulationCommon Bile Duct Neoplasmsmensmoking03 medical and health sciencesInternal medicinesmoking.HumansObesityRisk factoreducationLife StyleAgedbiliary tract carcinomaHepatologybusiness.industryCase-control studyOdds ratiomedicine.diseaseConfidence interval[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieCase-Control Studies[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiegallbladder carcinomabusinessBody mass index
researchProduct

In the literature: June 2019

2019

Biliary tract cancer (BTC) includes cholangiocarcinoma and gallbladder cancer. BTCs are known to have a poor prognosis, with a 5-year overall survival below 20%.1 Unfortunately, majority of patients are diagnosed with advanced stage, being palliative chemotherapy with cisplatin and gemcitabine the current standard of care.2 Poor prognosis is due to the fact that only 20% of patients are diagnosed in early stages3 and the high risk of relapse following curative surgery. Unfortunately, the lack of randomised studies has made the role of adjuvant treatment in BTC following surgery an unresolved matter for many years.4 5 Adjuvant therapy (either in the form of chemotherapy or chemoradiotherapy)…

OncologyCancer Researchmedicine.medical_specialtybusiness.industryliteratureGemOxNewsmedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogenslcsh:RC254-282GemcitabineBile duct cancerOxaliplatinCapecitabineOncologyInternal medicinemedicineAdjuvant therapy1506Gallbladder cancerbusinessChemoradiotherapymedicine.drugESMO Open
researchProduct

Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: a double-blind placebo-controlled multicentre phase II AIO stud…

2014

Background: Since sorafenib has shown activity in different tumour types and gemcitabine regimens improved the outcome for biliary tract cancer (BTC) patients, we evaluated first-line gemcitabine plus sorafenib in a double-blind phase II study. Patients and methods: 102 unresectable or metastatic BTC patients with histologically proven adenocarcinoma of gallbladder or intrahepatic bile ducts, Eastern Cooperative Oncology Group (ECOG) 0–2 were randomised to gemcitabine (1000 mg/m2 once weekly, first 7-weeks + 1-week rest followed by once 3-weeks + 1-week rest) plus sorafenib (400 mg twice daily) or placebo. Treatment continued until progression or unacceptable toxicity. Tumour samples were p…

OncologyMaleCancer ResearchAdvanced biliary tract cancerPDGFRβPhases of clinical researchHif1αKaplan-Meier Estimateurologic and male genital diseasesGastroenterologyDeoxycytidineMetastasisAntineoplastic Combined Chemotherapy Protocolsheterocyclic compoundsProspective StudiesLymph nodeAged 80 and overVascular Endothelial Growth FactorsMiddle AgedSorafenibBTCfemale genital diseases and pregnancy complicationsmedicine.anatomical_structureBiliary Tract NeoplasmsTreatment OutcomeOncologyAdenocarcinomaFemaleGallbladder NeoplasmsHand-Foot Syndromemedicine.drugSorafenibAdultNiacinamidemedicine.medical_specialtyPlaceboDisease-Free SurvivalDrug Administration ScheduleDouble-Blind MethodInternal medicinemedicineBiomarkers TumorHumansddc:610neoplasmsAgedbusiness.industryGallbladderPhenylurea Compoundsmedicine.diseaseVascular Endothelial Growth Factor Receptor-2Gemcitabinedigestive system diseasesGemcitabineChemokine CXCL12VEGFR-3VEGFR-2Bile Ducts IntrahepaticBile Duct Neoplasmsc-kitQuality of LifebusinessEuropean journal of cancer (Oxford, England : 1990)
researchProduct

Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyur…

1996

BACKGROUND To date there is no established chemotherapeutic treatment for patients with unresectable locally advanced and/or metastatic carcinomas of the exocrine pancreas or the gallbladder. A multicenter Phase II trial has been performed by the Southern Italy Oncology Group with the aim of evaluating the clinical effectiveness and tolerability of weekly 5-fluorouracil (5-FU) in modulation with intravenous (i.v.) high dose levofolinic acid and oral hydroxyurea. METHODS A total of 70 patients fulfilling the standard eligibility for a Phase II study were enrolled in the trial. Forty patients had advanced pancreatic adenocarcinoma and 30 had advanced gallbladder carcinoma. The treatment sched…

OncologyMaleCancer Researchmedicine.medical_specialtyAntimetabolites AntineoplasticPancreatic diseaseAntidotesLeucovorinPhases of clinical researchAdministration OralAntineoplastic AgentsAdenocarcinomaGastroenterologyDrug Administration ScheduleMetastatic carcinomaInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineCarcinomaHumansHydroxyureaInfusions IntravenousAgedbusiness.industryGallbladderCarcinomaRemission InductionLeukopeniaMiddle Agedmedicine.diseasePancreatic NeoplasmsSurvival Ratemedicine.anatomical_structureOncologyTolerabilityItalyInjections IntravenousDisease ProgressionAdenocarcinomaFemaleGallbladder NeoplasmsFluorouracilbusinessProgressive diseaseCancer
researchProduct

Concomitant Small Cell Neuroendocrine Carcinoma of Gallbladder and Breast Cancer

2014

The neuroendocrine carcinoma is defined as a high-grade malignant neuroendocrine neoplasm arising from enterochromaffin cells, usually disposed in the mucosa of gastric and respiratory tracts. The localization in the gallbladder is rare. Knowledge of these gallbladder tumors is limited and based on isolated case reports. We describe a case of an incidental finding of small cell neuroendocrine carcinoma of the gallbladder, observed after cholecystectomy for cholelithiasis, in a 55-year-old female, who already underwent quadrantectomy and sentinel lymph-node biopsy for breast cancer. The patient underwent radiotherapy for breast cancer and six cycles of chemotherapy with cisplatin and etoposi…

Pathologymedicine.medical_specialtybusiness.industryGallbladdermedicine.medical_treatmentlcsh:SurgeryCase Reportlcsh:RD1-811Settore MED/08 - Anatomia PatologicaMalignancymedicine.diseaseRadiation therapySettore MED/18 - Chirurgia Generalemedicine.anatomical_structureBreast cancerNeuroendocrine carcinomamedicineEnterochromaffin cellPharmacology (medical)CholecystectomyNeoplastic transformationbusinessQuadrantectomy
researchProduct

Xanthogranulomatous Cholecystitis

1990

Summary Xanthogranulomatous cholecystitis (XC) is a chronic inflammatory lesion of the gallbladder histologically characterized by the presence of varying amounts of foamy histiocytes in the inflammatory infiltrate. In this study a review of 63 cases selected from 1207 surgically removed gallbladders is presented; the percentage found (5.2%) is slightly higher than that of previous reports showing that XC is less uncommon than generally believed. A detailed microscopic study is performed: the authors observed according to the histological features particularly the different patterns of distribution of the inflammatory infiltrate and postulate the existence of three subtypes of XC: multinodu…

Pathologymedicine.medical_specialtymedicine.anatomical_structurebusiness.industryGallbladdermedicineCell BiologyFoamy histiocytesbusinessInflammatory lesionXanthogranulomatous CholecystitisPathology and Forensic MedicinePathology - Research and Practice
researchProduct

Are morphology and composition of gallstones related? An x-ray diffraction study

1994

Abstract An x-ray diffractometric technique was used to study the crystalline composition of gallstones removed during surgery from 106 patients. Monohydrate cholesterol was found in the stones of 70 (66%) patients, either alone (33%) or in association with calcium salts (33%). The anhydrous form of cholesterol was found in the stones of 28 (26%) patients, either alone (10%) or in association with calcium salts (16%). These salts (vaterite, aragonite, and calcite) were found in 50% of cases in varying amounts (from 12% to 15% of the stone weight). Eight stones contained no cholesterol: 4 showed an amorphous pattern and 4 were composed of calcium carbonate salts. In 7 of 8 patients with bile…

PharmacologyCalcitemedicine.medical_specialtyBile ductbusiness.industryCholesterolAragoniteGallstonesengineering.materialGallbladder Stonemedicine.diseaseSurgerychemistry.chemical_compoundmedicine.anatomical_structureCalcium carbonatechemistryVateriteengineeringmedicinePharmacology (medical)businessNuclear chemistryCurrent Therapeutic Research
researchProduct

Sludge and stones in gallbladder after pregnancy

1987

Summary The prevalence of sludge and stones in the gallbladder of 298 women in the immediate post-partum period was ultrasonographically assessed. We have investigated some risk factors for the development of sludge or stones in these patients and followed up most of these patients by ultrasonography to detect the presence of sludge and/or stones in the year following their discovery. We found sludge in 80 (26.2%) and gallstones in 16 (5.2%) of these patients. Age, obesity and months of oral contraceptive use were risk factors only for the presence of gallstones. After 1 year of follow-up only 2 out of 45 patients with sludge but 13 out of 15 patients with gallstones still had abnormal ultr…

Pregnancymedicine.medical_specialtyHepatologybusiness.industryGallbladderGallstonesmedicine.diseaseGastroenterologyObesityContraceptive usemedicine.anatomical_structureInternal medicinemedicineUltrasonographybusinessJournal of Hepatology
researchProduct

Electrospun Polyhydroxyethyl-Aspartamide-Polylactic Acid Scaffold for Biliary Duct Repair: A Preliminary In Vivo Evaluation

2017

Abstract Tissue engineering has emerged as a new approach with the potential to overcome the limitations of traditional therapies. The objective of this study was to test whether our polymeric scaffold is able to resist the corrosive action of bile and to support a cell's infiltration and neoangiogenesis with the aim of using it as a biodegradable tissue substitute for serious bile duct injuries. In particular, a resorbable electrospun polyhydroxyethyl-aspartamide–polylactic acid (90 mol% PHEA, 10 mol% PLA)/polycaprolactone (50:50 w/w) plate scaffold was implanted into rabbit gallbladder to assess the in vivo effects of the lytic action of the bile on the scaffold structure and then as a tu…

ScaffoldMaterials sciencePolyesters03 medical and health scienceschemistry.chemical_compound0302 clinical medicineBioabsorbable scaffold Bioengineered biliary duct Experimental surgeryTissue engineeringPolylactic acidIn vivomedicineAnimalsTransplantationTissue EngineeringTissue ScaffoldsBile ductGallbladderBiliary Tract Surgical ProceduresSettore MED/18 - Chirurgia Generalemedicine.anatomical_structurechemistryBiliary tractSettore CHIM/09 - Farmaceutico Tecnologico Applicativo030220 oncology & carcinogenesisPolycaprolactone030211 gastroenterology & hepatologySurgeryBile DuctsRabbitsBiomedical engineering
researchProduct